Literature DB >> 15184117

Metabolism of zearalenone by genetically modified organisms expressing the detoxification gene from Clonostachys rosea.

Naoko Takahashi-Ando1, Shuichi Ohsato, Takehiko Shibata, Hiroshi Hamamoto, Isamu Yamaguchi, Makoto Kimura.   

Abstract

Zearalenone (ZEN) is converted to a nontoxic product by a lactonohydololase encoded by zhd101. An enhanced green fluorescent protein (EGFP) gene was fused to zhd101 (i.e., egfp::zhd101) and expressed in Escherichia coli. Both recombinant ZHD101 and EGFP::ZHD101 were purified to homogeneity and characterized. Maximal activity of ZHD101 toward ZEN was measured at approximately 37 to 45 degrees C and pH 10.5 (k(cat) at 30 degrees C, 0.51 s(-1)). The enzyme was irreversibly inactivated at pH values below 4.5 or by treatment with serine protease inhibitors. ZHD101 was also active against five ZEN cognates, although the efficiencies were generally low; e.g., the k(cat) was highest with zearalanone (1.5 s(-1)) and lowest with beta-zearalenol (0.075 s(-1)). EGFP::ZHD101 had properties similar to those of the individual proteins with regard to the EGFP fluorescence and lactonohydrolase activity. Fortuitously, EGFP::ZHD101 exhibited a good correlation between the fluorescence intensity and reaction velocity under various pH conditions. We therefore used egfp::zhd101 to visually monitor the lactonohydrolase activity in genetically modified organisms and evaluated the usefulness of zhd101 for in vivo detoxification of ZEN. While recombinant E. coli and transgenic rice calluses exhibited strong EGFP fluorescence and completely degraded ZEN in liquid media, recombinant Saccharomyces cerevisiae gave poor fluorescence and did not eliminate all the toxicity of the mycotoxin in the medium; i.e., the rest of ZEN was transformed into an unfavorable substrate, beta-zearalenol, by an as-yet-unidentified reductase and remained in the medium. Even so, as much as 75% of ZEN was detoxified by the yeast transformant, which is better than the detoxification system in which food-grade Lactobacillus strains are used (H. El-Nezami, N. Polychronaki, S. Salminen, and H. Mykkuäne, Appl. Environ. Microbiol. 68:3545-3549, 2002). An appropriate combination of a candidate host microbe and the codon-optimized synthetic gene may contribute significantly to establishing a mycotoxin detoxification system for food and feed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184117      PMCID: PMC427733          DOI: 10.1128/AEM.70.6.3239-3245.2004

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  29 in total

1.  Efficient screening for catalytic antibodies using a short transition-state analog and detailed characterization of selected antibodies.

Authors:  N Takahashi; H Kakinuma; K Hamada; K Shimazaki; K Takahashi; S Niihata; Y Aoki; H Matsushita; Y Nishi
Journal:  Eur J Biochem       Date:  1999-04

Review 2.  The release of genetically modified crops into the environment. Part I. Overview of current status and regulations.

Authors:  Jan-Peter Nap; Peter L J Metz; Marga Escaler; Anthony J Conner
Journal:  Plant J       Date:  2003-01       Impact factor: 6.417

Review 3.  Risk assessment of the mycotoxin zearalenone.

Authors:  T Kuiper-Goodman; P M Scott; H Watanabe
Journal:  Regul Toxicol Pharmacol       Date:  1987-09       Impact factor: 3.271

4.  Effects of zearalenone (F2) on estrous activity and reproduction in gilts.

Authors:  M Etienne; M Jemmali
Journal:  J Anim Sci       Date:  1982-07       Impact factor: 3.159

5.  Monitoring transfer of recombinant and nonrecombinant plasmids between Lactococcus lactis strains and members of the human gastrointestinal microbiota in vivo--impact of donor cell number and diet.

Authors:  K Tuohy; M Davies; P Rumsby; C Rumney; M R Adams; I R Rowland
Journal:  J Appl Microbiol       Date:  2002       Impact factor: 3.772

6.  Biotransformation of the mycotoxin, zearalenone, to a non-estrogenic compound by a fungal strain of Clonostachys sp.

Authors:  Hideaki Kakeya; Naoko Takahashi-Ando; Makoto Kimura; Rie Onose; Isamu Yamaguchi; Hiroyuki Osada
Journal:  Biosci Biotechnol Biochem       Date:  2002-12       Impact factor: 2.043

7.  Genetically modified industrial yeast ready for application.

Authors:  Rinji Akada
Journal:  J Biosci Bioeng       Date:  2002       Impact factor: 2.894

8.  Metabolism of the Fusarium mycotoxins zearalenone and deoxynivalenol by yeast strains of technological relevance.

Authors:  C Böswald; G Engelhardt; H Vogel; P R Wallnöfer
Journal:  Nat Toxins       Date:  1995

9.  Expression in cereal plants of genes that inactivate Fusarium mycotoxins.

Authors:  Arisa Higa; Makoto Kimura; Kouhei Mimori; Tetsuko Ochiai-Fukuda; Takeshi Tokai; Naoko Takahashi-Ando; Takumi Nishiuchi; Tomoko Igawa; Makoto Fujimura; Hiroshi Hamamoto; Ron Usami; Isamu Yamaguchi
Journal:  Biosci Biotechnol Biochem       Date:  2003-04       Impact factor: 2.043

10.  A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae.

Authors:  R S Sikorski; P Hieter
Journal:  Genetics       Date:  1989-05       Impact factor: 4.562

View more
  23 in total

1.  Heterologous expression of Arabidopsis UDP-glucosyltransferases in Saccharomyces cerevisiae for production of zearalenone-4-O-glucoside.

Authors:  Brigitte Poppenberger; Franz Berthiller; Herwig Bachmann; Doris Lucyshyn; Clemens Peterbauer; Rudolf Mitterbauer; Rainer Schuhmacher; Rudolf Krska; Josef Glössl; Gerhard Adam
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

2.  Reduced contamination by the Fusarium mycotoxin zearalenone in maize kernels through genetic modification with a detoxification gene.

Authors:  Tomoko Igawa; Naoko Takahashi-Ando; Noriyuki Ochiai; Shuichi Ohsato; Tsutomu Shimizu; Toshiaki Kudo; Isamu Yamaguchi; Makoto Kimura
Journal:  Appl Environ Microbiol       Date:  2007-01-05       Impact factor: 4.792

Review 3.  Microbial detoxification of mycotoxins.

Authors:  Susan P McCormick
Journal:  J Chem Ecol       Date:  2013-07-12       Impact factor: 2.626

4.  Adsorption and degradation of zearalenone by bacillus strains.

Authors:  Samuel Edgar Tinyiro; Cuthbert Wokadala; Dan Xu; Weirong Yao
Journal:  Folia Microbiol (Praha)       Date:  2011-06-07       Impact factor: 2.099

5.  Cleavage of zearalenone by Trichosporon mycotoxinivorans to a novel nonestrogenic metabolite.

Authors:  Elisavet Vekiru; Christian Hametner; Rudolf Mitterbauer; Justyna Rechthaler; Gerhard Adam; Gerd Schatzmayr; Rudolf Krska; Rainer Schuhmacher
Journal:  Appl Environ Microbiol       Date:  2010-01-29       Impact factor: 4.792

6.  A model transgenic cereal plant with detoxification activity for the estrogenic mycotoxin zearalenone.

Authors:  Arisa Higa-Nishiyama; Naoko Takahashi-Ando; Tsutomu Shimizu; Toshiaki Kudo; Isamu Yamaguchi; Makoto Kimura
Journal:  Transgenic Res       Date:  2005-10       Impact factor: 2.788

Review 7.  Microbial and enzymatic battle with food contaminant zearalenone (ZEN).

Authors:  Bilal Murtaza; Xiaoyu Li; Liming Dong; Muhammad Tariq Javed; Le Xu; Muhammad Kashif Saleemi; Gen Li; Bowen Jin; Huijing Cui; Ashiq Ali; Lili Wang; Yongping Xu
Journal:  Appl Microbiol Biotechnol       Date:  2022-06-15       Impact factor: 4.813

Review 8.  Zearalenone lactonase: characteristics, modification, and application.

Authors:  Yuanyuan Fang; Zhenxia Zhang; Wei Xu; Wenli Zhang; Cuie Guang; Wanmeng Mu
Journal:  Appl Microbiol Biotechnol       Date:  2022-09-29       Impact factor: 5.560

9.  The predicted secretome of the plant pathogenic fungus Fusarium graminearum: a refined comparative analysis.

Authors:  Neil A Brown; John Antoniw; Kim E Hammond-Kosack
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

10.  A new zearalenone biodegradation strategy using non-pathogenic Rhodococcus pyridinivorans K408 strain.

Authors:  Rókus Kriszt; Csilla Krifaton; Sándor Szoboszlay; Mátyás Cserháti; Balázs Kriszt; József Kukolya; Arpád Czéh; Szilvia Fehér-Tóth; Lívia Török; Zsuzsanna Szőke; Krisztina J Kovács; Teréz Barna; Szilamér Ferenczi
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.